Explore tweets tagged as #masterprotocols
How can #masterprotocols help #biopharma companies improve #RnD productivity? https://t.co/5QDXWMZpbw
0
5
8
#MasterProtocols can provide opportunities for flexibility in the highly regulated #clinicaldevelopment industry which needs to operate with safety. Read the article to know about the types of designs in Master Protocols for #ClinicalTrials
#Veeda #BasketTrials #UmbrellaTrials
0
0
2
Need cancer drug development guidance? Check out 7 #FDAOncology guidances posted so far this year. #clinicaltrials #cnsmets #breastcancer #masterprotocols #pediatriconcology
https://t.co/kclrTc72ip
2
2
6
Happy to see potential DMOAD presentation at #BiologicsAlliance!!! Next gap for alliance to address- #MasterProtocols for early #Osteoarthritis #PTOA #patientengagement
0
0
1
.@DrWoodcockFDA Operation WarpSpeed presenting @CTTI_Trials public summit on advancing #masterprotocols – fastest path to effective #COVID19 treatments Dr. Derek Angus of @UPMC presenting on @remap_cap among other panelists
0
0
3
#Cytel is excited to host a #webinar series focusing on Expanding Applications of Master Protocols. As master protocols become more commonly used, Cytel presents on their broader application across multiple settings. Register today! https://t.co/OsHHyDCyfp
#masterprotocols
0
0
1
Explore the benefits of master protocols >> https://t.co/SPjSYqIj0o
#COVID19 #oncology #clinicaltrials #masterprotocols
0
2
1
Next Tues: Join us for a public webinar to unveil new resources to assist with designing & running #masterprotocols for #clinicaltrials! https://t.co/SFyrLVYI3i
0
0
1
Join us 10/13 for a public webinar to unveil new resources for designing & running #masterprotocols to increase #clinicaltrial efficiency. https://t.co/SFyrLVYI3i
0
1
2
.@hmkyale: “We need to do better for #COVID19 and far beyond...it’s time to move on that.” Greater #diversity, embrace #tech, #masterprotocols, #incentives & much more needs to happen to change #clinicaltrial culture.
0
0
1
Could you leverage #masterprotocols to improve the efficiency of your #clinicaltrials? Watch the webinar on our new resources to help you get started! https://t.co/d2NI4kFW0L
0
3
4
Hear from our experts at #WVCDC on Wednesday, 20 April! 𝟭𝟭:𝟰𝟬 𝗮.𝗺. 𝗘𝗧: Cyrille Bonhomme on #vaccineefficacy 𝟭𝟮:𝟭𝟬 𝗽.𝗺. 𝗘𝗧: Anusha Streubel and Trang Grisler on #masterprotocols If you have any post-session questions, our team would love to chat at booth 400!
0
2
2
Recording now available! CTTI launches new set of robust resources for collaboration, communication, & design of #masterprotocols. https://t.co/d2NI4kFW0L
0
0
1
What’s the best way to get started with designing #masterprotocols to increase the efficiency of your #clinicaltrials? Join us 10/13 as CTTI releases new resources for designing & running master protocols! https://t.co/SFyrLVYI3i
0
1
0
Join #BioNJ THIS THURSDAY for a FREE webinar on how Master Protocols are transforming clinical trials. Register today! https://t.co/BLJvEAuJv4
#ClinicalTrials #Webinar #MasterProtocols #ClinicalResearch #PatientCare
0
0
0
We've now got a full agenda for the day! REGISTER TODAY to secure yourself a spot for in-person or online attandence: https://t.co/sccdCzgQus
#statistics #clinicaltrials #adaptivedesigns #masterprotocols #sequential #decisionmaking
0
0
1
Did you miss the launch of our new resources to assist with the design & conduct of #masterprotocols? A recording is now available! https://t.co/d2NI4kFW0L
0
0
1
CTTI to release new resources to help design #masterprotocols to streamline #clinicaltrials & quickly address #publichealth needs. Join us 10/13! https://t.co/SFyrLVYI3i
0
1
1
Have you thought about developing #masterprotocols to streamline your #clinicaltrials? If not, why not now? Learn how to get started as CTTI releases new resources on 10/13! https://t.co/SFyrLVYI3i
0
0
1
The world owes thanks to the #masterprotocols from WHO. Big kudos to @derkarts and the team at @CastorEDC for providing the research technology that supported this vital research.
11,330 patients in an RCT across 30 countries “Remdesivir, hydroxychloroquine, lopinavir, and interferon had little or no effect on hospitalized pts w Covid-19, as indicated by overall mortality, initiation of ventilation, and duration of hospital stay.” https://t.co/EEOUrozkVE
0
1
4